308 related articles for article (PubMed ID: 35874511)
1. A Sedentary and Unhealthy Lifestyle Fuels Chronic Disease Progression by Changing Interstitial Cell Behaviour: A Network Analysis.
Huston P
Front Physiol; 2022; 13():904107. PubMed ID: 35874511
[TBL] [Abstract][Full Text] [Related]
2. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
Rees S; Williams A
JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
[TBL] [Abstract][Full Text] [Related]
3. Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients.
Nasri H
Cell J; 2014; 15(4):378-80. PubMed ID: 24381864
[TBL] [Abstract][Full Text] [Related]
4. Barriers to cardiovascular disease secondary prevention care in the West Bank, Palestine - a health professional perspective.
Collier J; Kienzler H
Confl Health; 2018; 12():27. PubMed ID: 30026794
[TBL] [Abstract][Full Text] [Related]
5. What is the role of lifestyle behaviour change associated with non-communicable disease risk in managing musculoskeletal health conditions with special reference to chronic pain?
Dean E; Söderlund A
BMC Musculoskelet Disord; 2015 Apr; 16():87. PubMed ID: 25888381
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity network for chronic disease: A novel approach to understand type 2 diabetes progression.
Khan A; Uddin S; Srinivasan U
Int J Med Inform; 2018 Jul; 115():1-9. PubMed ID: 29779710
[TBL] [Abstract][Full Text] [Related]
7. Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice.
Gao S; Li L; Li L; Ni J; Guo R; Mao J; Fan G
J Mol Cell Cardiol; 2019 Dec; 137():59-70. PubMed ID: 31629735
[TBL] [Abstract][Full Text] [Related]
8. Testing a Dutch web-based tailored lifestyle programme among adults: a study protocol.
Schulz DN; Kremers SP; van Osch LA; Schneider F; van Adrichem MJ; de Vries H
BMC Public Health; 2011 Feb; 11():108. PubMed ID: 21324181
[TBL] [Abstract][Full Text] [Related]
9. Occupational lifestyle diseases: An emerging issue.
Sharma M; Majumdar PK
Indian J Occup Environ Med; 2009 Dec; 13(3):109-12. PubMed ID: 20442827
[TBL] [Abstract][Full Text] [Related]
10. Physical Activity Protects the Human Brain against Metabolic Stress Induced by a Postprandial and Chronic Inflammation.
Pruimboom L; Raison CL; Muskiet FA
Behav Neurol; 2015; 2015():569869. PubMed ID: 26074674
[TBL] [Abstract][Full Text] [Related]
11. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
Bellinger DL; Lorton D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
[TBL] [Abstract][Full Text] [Related]
12. Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit.
Vodovotz Y; Barnard N; Hu FB; Jakicic J; Lianov L; Loveland D; Buysse D; Szigethy E; Finkel T; Sowa G; Verschure P; Williams K; Sanchez E; Dysinger W; Maizes V; Junker C; Phillips E; Katz D; Drant S; Jackson RJ; Trasande L; Woolf S; Salive M; South-Paul J; States SL; Roth L; Fraser G; Stout R; Parkinson MD
Front Med (Lausanne); 2020; 7():585744. PubMed ID: 33415115
[TBL] [Abstract][Full Text] [Related]
13. Sedentary behaviour and physical activity are associated with biomarkers of endothelial dysfunction and low-grade inflammation-relevance for (pre)diabetes: The Maastricht Study.
Vandercappellen EJ; Koster A; Savelberg HHCM; Eussen SJPM; Dagnelie PC; Schaper NC; Schram MT; van der Kallen CJH; van Greevenbroek MMJ; Wesselius A; Schalkwijk CG; Kroon AA; Henry RMA; Stehouwer CDA
Diabetologia; 2022 May; 65(5):777-789. PubMed ID: 35119485
[TBL] [Abstract][Full Text] [Related]
14. Only Hyperuricemia with Crystalluria, but not Asymptomatic Hyperuricemia, Drives Progression of Chronic Kidney Disease.
Sellmayr M; Hernandez Petzsche MR; Ma Q; Krüger N; Liapis H; Brink A; Lenz B; Angelotti ML; Gnemmi V; Kuppe C; Kim H; Bindels EMJ; Tajti F; Saez-Rodriguez J; Lech M; Kramann R; Romagnani P; Anders HJ; Steiger S
J Am Soc Nephrol; 2020 Dec; 31(12):2773-2792. PubMed ID: 32938648
[TBL] [Abstract][Full Text] [Related]
15. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
16. Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation.
Rohm TV; Fuchs R; Müller RL; Keller L; Baumann Z; Bosch AJT; Schneider R; Labes D; Langer I; Pilz JB; Niess JH; Delko T; Hruz P; Cavelti-Weder C
Front Immunol; 2021; 12():668654. PubMed ID: 34054838
[TBL] [Abstract][Full Text] [Related]
17. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
18. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
Guarino M; Tosoni A; Nebuloni M
Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
[TBL] [Abstract][Full Text] [Related]
19. Immunopathogenesis and therapeutic potential of macrophage influx in diffuse parenchymal lung diseases.
Kulshrestha R; Dhanda H; Pandey A; Singh A; Kumar R
Expert Rev Respir Med; 2020 Sep; 14(9):917-928. PubMed ID: 32600077
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of CD147 on M1 macrophages induces differentiation of Th17 cells in the lung interstitial fibrosis.
Geng JJ; Zhang K; Chen LN; Miao JL; Yao M; Ren Y; Fu ZG; Chen ZN; Zhu P
Biochim Biophys Acta; 2014 Sep; 1842(9):1770-82. PubMed ID: 24932516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
